Psychedelics

Dr. Reid Robison Interviewed by Daily Hive

In an interview with The Daily Hive, Dr. Reid Robison, Chief Clinical Officer at Numinus, discusses

What Are the Benefits of Microdosing? | Goop

Numinus's VP of Psychedelic Neurology, Dr. Evan Lewis, chats with Kelly Martin from Goop to discu

Meet Payton Nyquvest | Psychedelia Magazine

Our CEO Payton Nyquvest goes in depth with Tom Zuber in the 2021 winter edition of Psychedelia magaz

MDMA-Assisted Therapy for PTSD: In conversation with Rick Doblin & Payton Nyquvest

Why is real world evidence important for psychedelic research and how do therapy and psychedelics wo

‘People are desperate to heal’: The push for psychedelic-assisted therapy in Canada

Numinus was featured on Global TV’s “The New Reality” show! The show details

There Is a Lot of Fungus Among Us

Coffee for immune support. Supplements for inflammation. And psychedelics promising relief from

Numinus to expand state-of-the-art psychedelics research laboratory

Cliquez ici pour la version française Numinus Bioscience adds research space, enhances contract

Numinus Wellness looking to position itself at the forefront of psychedelics for healing and wellness

Through its Bioscience lab, Numinus is the first public company in Canada to receive a licence to pr

Numinus Wellness’s trial for MDMA-assisted therapy is in pre-implementation stage

The study, which is in collaboration with MAPS Public Benefit Corporation (MAPS PBC), subsidiary of

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer

Cliquez ici pour la version française Acquisition of industry-leading instrument by Thermo Fishe

Company with Nanaimo lab gets federal approval for psychedelic drug research

Numinus' recently amended Health Canada licence allows the company to produce and extract psilocybin

Healthcare company Numinus believes psychedelic assisted therapy can improve mental health outcomes

Numinus CEO, Payton Nyquvest, and Chief Medical Officer, Dr. Evan Wood, discuss the potential of psy

Numinus announces Clinical Advisory Council to advance integrated wellness model

Advisors including Dr. Gabor Maté and Zach Walsh bring training and expertise in psychedelic-assist

The business of producing psychedelics for science

The Daily Hive's Peter Smith speaks to Numinus CEO, Payton Nyquvest, about the business side of psyc

Numinus Announces 2020 Operational Plans to Scale

Company gives guidance on near-term business objectives VANCOUVER (May 28th, 2020)— Numinus Wel

Interior of a forest with dense trees and large rocks

Growing body of research shows patients with addiction, PTSD, and depression can benefit from psychedelic substances

In a discussion with CannCentral, Numinus Wellness Chief Medical Officer Dr. Evan Wood cautions that

Dark skinned young man sitting with his back against the wall and his hand resting against his forehead with his eyes closed

B.C. MP calls for legalization of some psychedelic drugs

CityNews TV talks to Numinus CEO Payton Nyquvest and advisor Gabor Mate about the future of psychede

Psilocybin Alpha speaks with Dr. Evan Wood, CMO at Numinus

In an interview with Psilocybin Alpha, Numinus Chief Medical Officer Dr. Evan Wood outlines his thou